Citigroup’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $145K | Sell |
21,016
-16,813
| -44% | -$116K | ﹤0.01% | 3499 |
|
2025
Q1 | $109K | Sell |
37,829
-11,893
| -24% | -$34.3K | ﹤0.01% | 3789 |
|
2024
Q4 | $234K | Sell |
49,722
-24,981
| -33% | -$117K | ﹤0.01% | 3499 |
|
2024
Q3 | $267K | Buy |
74,703
+51,912
| +228% | +$185K | ﹤0.01% | 3391 |
|
2024
Q2 | $141K | Sell |
22,791
-155,773
| -87% | -$966K | ﹤0.01% | 3332 |
|
2024
Q1 | $1.69M | Sell |
178,564
-106,734
| -37% | -$1.01M | ﹤0.01% | 1958 |
|
2023
Q4 | $1.93M | Buy |
285,298
+196,109
| +220% | +$1.32M | ﹤0.01% | 1674 |
|
2023
Q3 | $396K | Buy |
89,189
+81,286
| +1,029% | +$361K | ﹤0.01% | 2581 |
|
2023
Q2 | $26.1K | Buy |
7,903
+6,193
| +362% | +$20.4K | ﹤0.01% | 4214 |
|
2023
Q1 | $4.87K | Sell |
1,710
-43
| -2% | -$123 | ﹤0.01% | 4256 |
|
2022
Q4 | $12.8K | Sell |
1,753
-167
| -9% | -$1.22K | ﹤0.01% | 4056 |
|
2022
Q3 | $16K | Sell |
1,920
-1,820
| -49% | -$15.2K | ﹤0.01% | 4090 |
|
2022
Q2 | $18K | Sell |
3,740
-25,488
| -87% | -$123K | ﹤0.01% | 4358 |
|
2022
Q1 | $691K | Sell |
29,228
-11,205
| -28% | -$265K | ﹤0.01% | 2637 |
|
2021
Q4 | $715K | Buy |
40,433
+33,118
| +453% | +$586K | ﹤0.01% | 2834 |
|
2021
Q3 | $206K | Buy |
7,315
+396
| +6% | +$11.2K | ﹤0.01% | 3369 |
|
2021
Q2 | $73K | Buy |
6,919
+5,178
| +297% | +$54.6K | ﹤0.01% | 3974 |
|
2021
Q1 | $21K | Sell |
1,741
-1,851
| -52% | -$22.3K | ﹤0.01% | 4554 |
|
2020
Q4 | $42K | Buy |
3,592
+2,905
| +423% | +$34K | ﹤0.01% | 4209 |
|
2020
Q3 | $5K | Sell |
687
-1,050
| -60% | -$7.64K | ﹤0.01% | 4653 |
|
2020
Q2 | $32K | Sell |
1,737
-1,942
| -53% | -$35.8K | ﹤0.01% | 3967 |
|
2020
Q1 | $44K | Buy |
3,679
+2,767
| +303% | +$33.1K | ﹤0.01% | 3868 |
|
2019
Q4 | $15K | Buy |
912
+673
| +282% | +$11.1K | ﹤0.01% | 4589 |
|
2019
Q3 | $2K | Buy |
+239
| New | +$2K | ﹤0.01% | 4959 |
|